As plans become more likely pharmacy managers CVS Health, Express Scripts and Walgreens crashed into correction or bear market territory.
Eli Lilly is a holding of Jim Cramer's charitable trust, Action Alerts PLUS.
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Thursday's trending stocks.
Morgan Stanley analysts upgraded shares of Biogen and downgraded shares of Celgene over concerns of generic drug pressures. TheStreet's Jim Cramer called these moves "useless."
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Wednesday's trending stocks.
Mylan scored FDA approval for a generic version of Teva Pharmaceuticals' multiple sclerosis drug, Copaxone.
The Israeli pharma company Teva has established a rich history since its founding in 1901. Can it continue to survive as it faces one challenge after another?
Jim Cramer explains why his Action Alerts Plus charitable portfolio is hanging on to Abbott Laboratories.
Working Mother and the National Association of Female Executives surveyed companies and found the best ones that do right by women. Find out who you should be working for.
Johnson & Johnson had a very good acquisition